Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Hypertension IV: Drug Therapy and Lifestyle Modifications

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...

Overview of Lipid Metabolism

Overview of Lipid Metabolism

Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...

Lipid Absorption

Lipid Absorption

Dietary triglycerides from chyme in the duodenum are mixed with bile salts produced by the liver to emulsify fats. As a result, large droplets are broken down into smaller ones, increasing the surface area for enzymatic action. Once emulsified, pancreatic lipases hydrolyze the triglycerides into free fatty acids and monoglycerides.
These breakdown products bind with bile salts and lecithin to form micelles, which quickly pass between microvilli to come in close contact with the apical...

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Procollagen type I N-propeptide is a predictor of skeletal morbidity in patients with malignant osteolytic bone disease on bisphosphonates.

Cancer chemotherapy and pharmacology·2010

Same author

Bevacizumab-associated hyperlipoproteinemia type IIb in a patient with advanced invasive-ductal breast cancer.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2010

Same author

Elevation of the serum total and free prostate-specific antigen levels after stent implantation in patient with coronary artery disease.

Swiss medical weekly·2009

Same author

[Comment from the lipidologic viewpoint].

Praxis·2009

Same author

Hypertriglyceridemia as a possible risk factor for prostate cancer.

Prostate cancer and prostatic diseases·2005

Same author

[Protective effects of pravastatin against atherosclerosis in children with familial hypercholesterolemia].

Revue medicale suisse·2005

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Update of lipid lowering therapy].

W F Riesen¹, R C Mordasini

¹Institut für Klinische Chemie und Hämatologie, Kantonsspital St. Gallen. walter.riesen@ikch.ch

|November 4, 2008

Summary

Dyslipidemia significantly increases cardiovascular risk. Current guidelines recommend lipid-lowering therapy based on overall patient risk, with statins being a generally safe option when used appropriately.

Area of Science:

Cardiology
Metabolic Disorders
Pharmacology

Context:

Dyslipidemia is a major modifiable risk factor for cardiovascular disease.
Effective lipid management is crucial for cardiovascular event prevention.
Current guidelines emphasize a global risk assessment approach for initiating therapy.

Purpose:

To outline the principles of lipid management in clinical practice.
To discuss the selection of lipid-lowering therapies based on lipid profiles.
To highlight considerations regarding target values and safety profiles of treatments.

Summary:

Lipid management strategies should align with a patient's global cardiovascular risk.
Therapeutic choices must be tailored to specific lipid abnormalities, considering efficacy and safety.

Related Experiment Videos

Last Updated: Jun 28, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

Statins are commonly used but require monitoring for potential side effects like hepatotoxicity and myopathy.

Lifestyle modifications are fundamental to all lipid management plans.

Impact:

Informing clinical decision-making for optimizing dyslipidemia treatment.
Improving patient outcomes by reducing cardiovascular risk through targeted lipid management.
Guiding healthcare professionals in selecting appropriate and safe lipid-lowering therapies.